As a result, and based on further consultations with the Health Security Committee, it is appropriate to amend Regulation (EU) 2021/953 to provide that certificates of recovery can also be issued following a positive result of a rapid antigen test listed in the EU common list and carried out by health professionals or by skilled testing personnel by the Member State where the test was carried out. The rapid antigen test used should be included in the EU common list at the time the test result was produced, and its possible subsequent removal from the EU common list should not affect the validity of certificates of recovery already issued.
Recital 9, Regulation (EU) 2022/256
In forcesince 22 Feb 2022
- celex=32021R0953